Ignite Creation Date:
2025-12-25 @ 4:13 AM
Ignite Modification Date:
2025-12-26 @ 3:13 AM
Study NCT ID:
NCT04681820
Status:
UNKNOWN
Last Update Posted:
2023-08-01
First Post:
2020-12-18
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Evaluating Efficacy and Safety of Flumatinib for Chronic Phase Chronic Myeloid Leukemia(CML-CP) Without Optimal Response (Warning,Failure) to Imatinib or Dasatinib
Sponsor:
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-11-01
Start Date Type:
ACTUAL
Primary Completion Date:
2023-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-11
Completion Date Type:
ESTIMATED
First Submit Date:
2020-12-18
First Submit QC Date:
None
Study First Post Date:
2020-12-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-07-26
Last Update Post Date:
2023-08-01
Last Update Post Date Type:
ACTUAL